Surgery for Advanced Adrenal Malignant Disease: Recommendations Based on European Society of Endocrine Surgeons Consensus Meeting

Overview

Journal Br J Surg

Specialty General Surgery

Date 2024 Jan 24

PMID 38265812

Authors

Radu Mihai

Carmela De Crea

Carole Guerin

Francesca Torresan

Orhan Agcaoglu

Razvan Simescu

Martin K Walz

Affiliations

Soon will be listed here.

Citing Articles

Urinary Dopamine Levels Can Predict the Avidity of Post-Therapy [I]MIBG Scintigraphy in Unresectable or Metastatic Pheochromocytomas and Paragangliomas: A Preliminary Clinical Study.

Takenaka J, Watanabe S, Abe T, Takeuchi S, Hirata K, Kimura R Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40005979 PMC: 11858449. DOI: 10.3390/ph18020165.

Impact of Obesity on Short-Term Outcomes in Patients Undergoing Retroperitoneal Laparoscopic/Retroperitoneoscopic Adrenalectomy for Benign or Malignant Adrenal Diseases: A Meta-Analysis.

Zizzo M, Morini A, Zanelli M, Grasselli C, Sanguedolce F, Wong S Medicina (Kaunas). 2025; 61(1).

PMID: 39859089 PMC: 11766650. DOI: 10.3390/medicina61010106.

Necrosis in Preoperative Cross-Sectional Imaging and Postoperative Histology Is a Diagnostic Marker for Malignancy of Adrenocortical Tumors.

Dukaczewska A, Marticorena Garcia S, Ponsel S, Webster A, Butz F, Dobrindt E Curr Oncol. 2025; 32(1.

PMID: 39851941 PMC: 11764034. DOI: 10.3390/curroncol32010025.

Pheochromocytoma: an updated scoping review from clinical presentation to management and treatment.

Saavedra T J, Nati-Castillo H, Valderrama Cometa L, Rivera-Martinez W, Asprilla J, Castano-Giraldo C Front Endocrinol (Lausanne). 2024; 15:1433582.

PMID: 39735644 PMC: 11671257. DOI: 10.3389/fendo.2024.1433582.

A Review on Mitotane: A Target Therapy in Adrenocortical Carcinoma.

Flauto F, De Martino M, Vitiello C, Pivonello R, Colao A, Damiano V Cancers (Basel). 2024; 16(23).

PMID: 39682247 PMC: 11640523. DOI: 10.3390/cancers16234061.

References

Zhang F, Liu Z, Liang J, Tang Y, Liu S, Zhou C . Operative intervention for recurrence of adrenocortical carcinoma: A single-center experience. Surgery. 2020; 169(5):1131-1138. DOI: 10.1016/j.surg.2020.10.041. View

Katoh N, Onishi H, Uchinami Y, Inoue T, Kuriyama K, Nishioka K . Real-Time Tumor-Tracking Radiotherapy and General Stereotactic Body Radiotherapy for Adrenal Metastasis in Patients With Oligometastasis. Technol Cancer Res Treat. 2018; 17:1533033818809983. PMC: 6259059. DOI: 10.1177/1533033818809983. View

Brito J, Asi N, Gionfriddo M, Norman C, Leppin A, Zeballos-Palacios C . The incremental benefit of functional imaging in pheochromocytoma/paraganglioma: a systematic review. Endocrine. 2015; 50(1):176-86. DOI: 10.1007/s12020-015-0544-7. View

Autorino R, Bove P, De Sio M, Miano R, Micali S, Cindolo L . Open Versus Laparoscopic Adrenalectomy for Adrenocortical Carcinoma: A Meta-analysis of Surgical and Oncological Outcomes. Ann Surg Oncol. 2015; 23(4):1195-202. DOI: 10.1245/s10434-015-4900-x. View

Gill A . Succinate dehydrogenase (SDH)-deficient neoplasia. Histopathology. 2017; 72(1):106-116. DOI: 10.1111/his.13277. View

Bilek R, Zelinka T, Vlcek P, Duskova J, Michalsky D, Novak K . Radioimmunoassay of chromogranin A and free metanephrines in diagnosis of pheochromocytoma. Physiol Res. 2017; 66(Suppl 3):S397-S408. DOI: 10.33549/physiolres.933719. View

Wachtel H, Hutchens T, Baraban E, Schwartz L, Montone K, Baloch Z . Predicting Metastatic Potential in Pheochromocytoma and Paraganglioma: A Comparison of PASS and GAPP Scoring Systems. J Clin Endocrinol Metab. 2020; 105(12). PMC: 7553245. DOI: 10.1210/clinem/dgaa608. View

Rossi L, Becucci C, Ambrosini C, Puccini M, Chicas Vasquez M, Gjeloshi B . Surgical Management of Adrenocortical Carcinoma: A Literature Review. J Clin Med. 2022; 11(19). PMC: 9571837. DOI: 10.3390/jcm11195754. View

de Wolf J, Bellier J, Lepimpec-Barthes F, Tronc F, Peillon C, Bernard A . Exhaustive preoperative staging increases survival in resected adrenal oligometastatic non-small-cell lung cancer: a multicentre study. Eur J Cardiothorac Surg. 2017; 52(4):698-703. DOI: 10.1093/ejcts/ezx193. View

10.

Pierre C, Agopiantz M, Brunaud L, Battaglia-Hsu S, Max A, Pouget C . COPPS, a composite score integrating pathological features, PS100 and SDHB losses, predicts the risk of metastasis and progression-free survival in pheochromocytomas/paragangliomas. Virchows Arch. 2019; 474(6):721-734. DOI: 10.1007/s00428-019-02553-5. View

11.

Carrasquillo J, Chen C, Jha A, Pacak K, Pryma D, Lin F . Systemic Radiopharmaceutical Therapy of Pheochromocytoma and Paraganglioma. J Nucl Med. 2021; 62(9):1192-1199. PMC: 8882896. DOI: 10.2967/jnumed.120.259697. View

12.

Hope T, Abbott A, Colucci K, Bushnell D, Gardner L, Graham W . NANETS/SNMMI Procedure Standard for Somatostatin Receptor-Based Peptide Receptor Radionuclide Therapy with Lu-DOTATATE. J Nucl Med. 2019; 60(7):937-943. DOI: 10.2967/jnumed.118.230607. View

13.

Owen D, Patel S, Wei L, Phay J, Shirley L, Kirschner L . Metastatic Adrenocortical Carcinoma: a Single Institutional Experience. Horm Cancer. 2019; 10(4-6):161-167. PMC: 10355711. DOI: 10.1007/s12672-019-00367-0. View

14.

Cho Y, Kwak M, Lee S, Ahn S, Kim H, Suh S . A clinical prediction model to estimate the metastatic potential of pheochromocytoma/paraganglioma: ASES score. Surgery. 2018; 164(3):511-517. DOI: 10.1016/j.surg.2018.05.001. View

15.

Koh J, Ahn S, Kim H, Kim B, Sung T, Kim Y . Validation of pathological grading systems for predicting metastatic potential in pheochromocytoma and paraganglioma. PLoS One. 2017; 12(11):e0187398. PMC: 5678867. DOI: 10.1371/journal.pone.0187398. View

16.

Bilek R, Vlcek P, Safarik L, Michalsky D, Novak K, Duskova J . Chromogranin A in the Laboratory Diagnosis of Pheochromocytoma and Paraganglioma. Cancers (Basel). 2019; 11(4). PMC: 6521298. DOI: 10.3390/cancers11040586. View

17.

Beitler A, Urschel J, Velagapudi S, Takita H . Surgical management of adrenal metastases from lung cancer. J Surg Oncol. 1998; 69(1):54-7. DOI: 10.1002/(sici)1096-9098(199809)69:1<54::aid-jso11>3.0.co;2-n. View

18.

Fishbein L, Del Rivero J, Else T, Howe J, Asa S, Cohen D . The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma. Pancreas. 2021; 50(4):469-493. DOI: 10.1097/MPA.0000000000001792. View

19.

Ramsingh J, ODwyer P, Watson C . Survival outcomes following adrenalectomy for isolated metastases to the adrenal gland. Eur J Surg Oncol. 2019; 45(4):631-634. DOI: 10.1016/j.ejso.2019.01.006. View

20.

Deljou A, Kohlenberg J, Weingarten T, Bancos I, Young Jr W, Schroeder D . Hemodynamic instability during percutaneous ablation of extra-adrenal metastases of pheochromocytoma and paragangliomas: a case series. BMC Anesthesiol. 2018; 18(1):158. PMC: 6220566. DOI: 10.1186/s12871-018-0626-1. View